149 related articles for article (PubMed ID: 27306807)
1. [Oxaliplatin -- A 10-Year Trajectory].
Kanaji S; Oki E; Saeki H; Kitao H; Maehara Y; Kakeji Y
Gan To Kagaku Ryoho; 2016 Jun; 43(6):715-22. PubMed ID: 27306807
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
[TBL] [Abstract][Full Text] [Related]
3. [ASCO 2005: Progression with oxaliplatin in the treatment of colorectal neoplasms].
Longo F; Mansueto G
Tumori; 2005; 91(3):suppl 1-12. PubMed ID: 16206661
[No Abstract] [Full Text] [Related]
4. [January 2004: a month of success with oxaliplatin and hope for patients with colorectal cancer].
Tumori; 2004; 90(1):suppl 28-30. PubMed ID: 15143997
[No Abstract] [Full Text] [Related]
5. [Tolerability of Oxaliplatin-Based Adjuvant Chemotherapy for Patients with Colorectal Cancer].
Matsuo H; Nakanishi M; Arita T; Murayama Y; Kuriu Y; Kosuga T; Konishi H; Morimura R; Komatsu S; Shiozaki A; Ikoma H; Ichikawa D; Fujiwara H; Okamoto K; Otsuji E
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2112-4. PubMed ID: 26805281
[TBL] [Abstract][Full Text] [Related]
6. [Oxaliplatin in colorectal carcinoma: from palliation to cure].
Arnheim K
Onkologie; 2004 Aug; 27 Suppl 1():2-11. PubMed ID: 23570154
[No Abstract] [Full Text] [Related]
7. [Oxaliplatin: perspectives and future developments].
Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
[No Abstract] [Full Text] [Related]
8. [Introduction of oxaliplatin for treating unresectable advanced or recurrent gastric cancer in clinical practice].
Sato A
Gan To Kagaku Ryoho; 2015 Apr; 42(4):443-6. PubMed ID: 25963690
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Nukatsuka M; Nakagawa F; Takechi T
Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
[TBL] [Abstract][Full Text] [Related]
10. Optimizing oxaliplatin-based therapy in metastatic colorectal cancer.
Cassidy J
Clin Adv Hematol Oncol; 2008 May; 6(5):360-1. PubMed ID: 18516025
[No Abstract] [Full Text] [Related]
11. Clinical application of oxaliplatin in epithelial ovarian cancer.
Fu S; Kavanagh JJ; Hu W; Bast RC
Int J Gynecol Cancer; 2006; 16(5):1717-32. PubMed ID: 17009963
[TBL] [Abstract][Full Text] [Related]
12. A historical perspective on oxaliplatin: rethinking the role of platinum compounds and learning from near misses.
Cvitkovic E
Semin Oncol; 1998 Apr; 25(2 Suppl 5):1-3. PubMed ID: 9609102
[No Abstract] [Full Text] [Related]
13. [Oxaliplatin: a first DACH-platinum in oncology].
Laadem A; Cvitkovic E
Bull Cancer; 2001 Aug; 88 Spec No():S9-13. PubMed ID: 11567908
[TBL] [Abstract][Full Text] [Related]
14. [Oxaliplatin].
Furue H
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1195-202. PubMed ID: 16121929
[TBL] [Abstract][Full Text] [Related]
15. 1st Eloxatin Meeting, Budapest, Hungary, March 2002.
Harper P
Colorectal Dis; 2003 Nov; 5 Suppl 3():III. PubMed ID: 23573554
[No Abstract] [Full Text] [Related]
16. The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomas.
Hoff PM; Fuchs CS
Semin Oncol; 2003 Aug; 30(4 Suppl 15):54-61. PubMed ID: 14523796
[TBL] [Abstract][Full Text] [Related]
17. Recent updates in the clinical use of platinum compounds for the treatment of gastrointestinal cancers.
Haller DG
Semin Oncol; 2004 Dec; 31(6 Suppl 14):10-6. PubMed ID: 15726529
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin in colorectal cancer: an overview.
Armand JP; Boige V; Raymond E; Fizazi K; Faivre S; Ducreux M
Semin Oncol; 2000 Oct; 27(5 Suppl 10):96-104. PubMed ID: 11049040
[No Abstract] [Full Text] [Related]
19. [Oxaliplatin in colorectal cancer].
Boni C; Banzi M
Tumori; 2001; 87(1 Suppl 1):S51-2. PubMed ID: 11300025
[No Abstract] [Full Text] [Related]
20. Phase 1 study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases.
Takahashi M; Hasegawa K; Oba M; Saiura A; Arita J; Sakamoto Y; Shinozaki E; Mizunuma N; Matsuyama Y; Kokudo N
Invest New Drugs; 2016 Aug; 34(4):468-73. PubMed ID: 27155613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
